24
Participants
Start Date
November 29, 2021
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
BCD-245
BCD-245 is administered as prolonged intravenous infusions during each cycle
RECRUITING
Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology, Moscow
RECRUITING
"Russian Cancer Research Center named after N.N. Blokhin of the Ministry of Health of the Russian Federation", Moscow
RECRUITING
Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation, Saint Petersburg
Lead Sponsor
Biocad
INDUSTRY